Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002568169 | SCV003681507 | uncertain significance | Inborn genetic diseases | 2021-10-06 | criteria provided, single submitter | clinical testing | The c.1843G>C (p.A615P) alteration is located in exon 11 (coding exon 11) of the CEL gene. This alteration results from a G to C substitution at nucleotide position 1843, causing the alanine (A) at amino acid position 615 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Ce |
RCV001529789 | SCV004156678 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | CEL: BS1, BS2 |
Breakthrough Genomics, |
RCV001529789 | SCV005226018 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV001529789 | SCV001743868 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001529789 | SCV001965185 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001796590 | SCV002036080 | benign | not specified | no assertion criteria provided | clinical testing |